Citigroup
QGENF

Citigroup’s QIAGEN NV QGENF Stock Holding History

Citigroup’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,000
Closed -$65K – 7469
2016
Q2 		$65K Hold
3,000
– – ﹤0.01% 5407
2016
Q1 		$67K Hold
3,000
– – ﹤0.01% 5947
2015
Q4 		$83K Hold
3,000
– – ﹤0.01% 5523
2015
Q3 		$77K Buy
+3,000
New +$77K ﹤0.01% 5151

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Citigroup's QGENF Position: Q1 2017 in Review

Citigroup sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 159,431 shares — an estimated $4.47M sold.

Citigroup first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $12.5M in Q1 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Citigroup reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Citigroup sold 159,431 QIAGEN NV shares in Q1 2017, an estimated $4.47M.
  • Citigroup first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Citigroup's QIAGEN NV position peaked at $12.5M in Q1 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.